Clinical Trials in Baltimore

Showing 6361-6380 of 23,476 trials

Pioglitazone for Idiopathic Gastroparesis

NCT04300127

The principal objective of this pilot study will be to evaluate whether 8 weeks of treatment of pioglitazone will improve symptoms as measured by the Gastrointestinal Symptom Index (GCSI) in patients with Idiopathic Gastroparesis.

Gastroparesis

Johns Hopkins University14 participantsStarted Oct 2019

Baltimore, Maryland, United States

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome

NCT04129164

The purpose of the study is to evaluate the efficacy, safety, and tolerability of VIB4920 (formerly MEDI4920) in adult participants with Sjögren's Syndrome (SS).

Sjögren's Syndrome

Amgen183 participantsStarted Dec 2019

Fullerton, California, United States • Upland, California, United States • Lawrenceville, Georgia, United States +59 more locations

Pioglitazone for Idiopathic Gastroparesis

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome

Find Trials by Condition in Baltimore

54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide

54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis

A Study to Investigate the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itraconazole in Healthy Participants

Natural History Study of COVID-19 Using Digital Wearables

Maximizing the Reach of Universal Child Sexual Abuse Prevention: An Equivalence Trial

A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages in the Lumbar Spine

Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck

Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App